X0306 4 2021-05-04 0001099800 Edwards Lifesciences Corp EW 0001710625 Lemercier Jean-Luc M ONE EDWARDS WAY IRVINE CA 92614 1 CVP, EMEA, Canada, Latin Amer Common Stock 2021-05-04 4 A 0 2850.0000 0.0000 A 142391.1380 D Employee Stock Option (Right to Acquire) 93.3100 2021-05-04 4 A 0 27800.0000 0.0000 A 2022-05-04 2028-05-03 Common Stock 27800.0000 27800.0000 D Performance Rights 2021-05-04 4 A 0 3550.0000 0.0000 A 2024-05-04 2028-05-03 Common Stock 3550.0000 3550.0000 D These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 4, 2021 and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2021-05-06